32 / 76
CARDIOVASCULAR JOURNAL OF AFRICA • Volume 29, No 4, July/August 2018
230
AFRICA
MDH receives grant support from the World Heart Federation to serve as
its senior programme advisor for the Emerging Leaders programme, which
is supported by unrestricted educational grants from Boehringer Ingelheim
and Novartis, with previous support from AstraZeneca and Bupa. Funding
was provided by the Fogarty International Center TW R25TW009345. MDH
also receives support from the American Heart Association, Verily and
AstraZeneca that is unrelated to this article.
References
1.
Mensah GA. Descriptive epidemiology of cardiovascular risk factors
and diabetes in sub-Saharan Africa.
Prog Cardiovasc Dis
2013;
56
(3):
240–250.
2.
Onen CL. Epidemiology of ischaemic heart disease in sub-Saharan
Africa.
Cardiovasc J Afr
2013;
24
(2): 34–42.
3.
Hertz JT, Reardon JM, Rodrigues CG, de Andrade L, Limkakeng
AT, Bloomfield GS,
et al.
Acute myocardial infarction in sub-Saharan
Africa: the need for data.
PloS One
2014;
9
(5): e96688.
4.
Steg PG, Goldberg RJ, Gore JM, Fox KA, Eagle KA, Flather MD,
et al
. Baseline characteristics, management practices, and in-hospital
outcomes of patients hospitalized with acute coronary syndromes in the
Global Registry of Acute Coronary Events (GRACE).
Am J Cardiol
2002;
90
(4): 358–363.
5.
ICD-10 Version (2016). International Statistical Classification of
Diseases and Related Health Problems, 10th revision. Retrieved from
http://apps.who.int/classifcations/icd10.6.
Thygesen K, Jaffe AS, Simoons ML, Chaitman BR, White HD; Joint
ESC/ACCF/AHA/WHF Task Force for the Universal Definition of
Myocardial Infarction, Third universal definition of myocardial infarc-
tion.
Circulation
2012;
126
: 2020–2035.
7.
Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon
CP,
et al.
Predictors of hospital mortality in the global registry of acute
coronary events.
Arch Internal Med
2003;
163
(19): 2345–2353.
8.
StataCorp 2015. Stat Statistical Software: Release 14. College Station,
TX: StataCorp LP.
9.
O’Gara PT KG, Ascheim DD, Casey DE, Chung MK, De lemos JA,
Ettinger SM,
et al
. 2013 ACC/AHA guildeline for management of
ST-elevation myocardial infarction.
J Am Coll Cardiol
2013;
61
(4):
e78–e140.
10. Ogeng’o JA, Olabu BO, Ong’era D, Sinkeet SR. Pattern of acute
myocardial infarction in an African country.
Acta Cardiol
2010;
65
(6):
613–618.
11. Schamroth C. Management of acute coronary syndrome in South
Africa: insights from the ACCESS (Acute Coronary Events – a
Multinational Survey of Current Management Strategies) registry.
Cardiovasc J Afr
2012;
23
(7): 365–370.
12. Shavadia J, Yonga G, Otieno H. A prospective review of acute coronary
syndromes in an urban hospital in sub-Saharan Africa.
Cardiovasc J Afr
2012;
23
(6): 318–321.
13. Mohanan PP, Mathew R, Harikrishnan S, Krishnan MN, Zachariah G,
Joseph J,
et al.
Presentation, management, and outcomes of 25 748 acute
coronary syndrome admissions in Kerala, India: results from the Kerala
ACS Registry.
Eur Heart J
2013;
34
(2): 121–129.
14. Xu H, Li W, Yang J, Wiviott SD, Sabatine MS, Peterson ED,
et al
.
The China Acute Myocardial Infarction (CAMI) Registry: A national
long-term registry–research–education integrated platform for exploring
acute myocardial infarction in China.
Am Heart J
2016;
175
: 193–201.
e3.
15. Berwanger O, Guimaraes HP, Laranjeira LN, Cavalcanti AB, Kodama
AA, Zazula AD,
et al.
Effect of a multifaceted intervention on use of
evidence-based therapies in patients with acute coronary syndromes in
Brazil: the BRIDGE-ACS randomized trial.
J Am Med Assoc
2012;
307
(19): 2041–2049.
16. Li M, Huang Y, Du X, Li S, Ji J, Patel A,
et al.
Impact of Prior Use of
Four Preventive Medications on Outcomes in Patients Hospitalized for
Acute Coronary Syndrome – Results from CPACS-2 Study.
PloS One
2016;
11
(9): e0163068.
17. Huffman MD, Mohanan PP, Devarajan R, Baldridge AS, Kondal D,
Zhao L,
et al
. Acute coronary syndrome quality improvement in Kerala
(ACS QUIK): Rationale and design for a cluster-randomized stepped-
wedge trial.
Am Heart J
2017;
185
: 154–160.